Search research articles
Contact Us
Filters
Showing results (71-80 of 99) with videos related to
Page
of 10
Sort By:
Clinical and Experimental Immunology
|
April 23, 2013
Cellular immune function monitoring after allogeneic haematopoietic cell transplantation: evaluation of a new assay
M Israeli, T Klein, C Herscovici, et al.
AIDS Research and Human Retroviruses
|
May 1, 1992
Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro
A Vonsover, S Loya, B Sredni, et al.
Clinical and Experimental Dermatology
|
June 15, 2005
In vitro cytokine profile in childhood alopecia areata and the immunomodulatory effects of AS-101
M Shohat, D Mimouni, D Ben-Amitai, et al.
Journal of Neuroimmunology
|
July 1, 1994
Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage
M Huberman, F Shalit, I Roth-Deri, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1996
The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma
Y Kalechman, A Shani, S Dovrat, et al.
The Journal of Clinical Investigation
|
April 1, 1993
Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3
P Fishman, E Falach-Vaknine, R Zigelman, et al.
Leukemia
|
May 18, 2007
Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model
M Hayun, E Okun, R Hayun, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1990
Radioprotective effects of the immunomodulator AS101
Y Kalechman, M Albeck, M Oron, et al.
Oncogene
|
January 10, 2002
Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells
Y Dagon, S Dovrat, S Vilchik, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
February 1, 1996
Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndrome
P Fishman, E Falach-Vaknin, B Sredni, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 99) with videos related to
Sort By:
Page
of 10
Clinical and Experimental Immunology
|
April 23, 2013
Cellular immune function monitoring after allogeneic haematopoietic cell transplantation: evaluation of a new assay
M Israeli, T Klein, C Herscovici, et al.
AIDS Research and Human Retroviruses
|
May 1, 1992
Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro
A Vonsover, S Loya, B Sredni, et al.
Clinical and Experimental Dermatology
|
June 15, 2005
In vitro cytokine profile in childhood alopecia areata and the immunomodulatory effects of AS-101
M Shohat, D Mimouni, D Ben-Amitai, et al.
Journal of Neuroimmunology
|
July 1, 1994
Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage
M Huberman, F Shalit, I Roth-Deri, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1996
The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma
Y Kalechman, A Shani, S Dovrat, et al.
The Journal of Clinical Investigation
|
April 1, 1993
Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3
P Fishman, E Falach-Vaknine, R Zigelman, et al.
Leukemia
|
May 18, 2007
Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model
M Hayun, E Okun, R Hayun, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1990
Radioprotective effects of the immunomodulator AS101
Y Kalechman, M Albeck, M Oron, et al.
Oncogene
|
January 10, 2002
Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells
Y Dagon, S Dovrat, S Vilchik, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
February 1, 1996
Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndrome
P Fishman, E Falach-Vaknin, B Sredni, et al.
Page
of 10